The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

Neuron

Volumn 37, Issue 4, 2003, Pages 583-595

  Sharon, Ronit ^a   Bar Joseph, Ifat ^a   Frosch, Matthew P ^a   Walsh, Dominic M ^a   Hamilton, James A ^a   Selkoe, Dennis J ^a  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; OLIGOMER; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MESENCEPHALON; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; TRANSGENIC MOUSE;

EID: 0037456578     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00024-2     Document Type: Article

References (37)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A.et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 25:2000;239-252.
2. Auluck P.K., Chan H.Y., Trojanowski J.Q., Lee V.M., Bonini N.M. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:2002;865-868.
3. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884.
4. Bonen A., Dyck D.J., Ibrahimi A., Abumrad N.A. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am. J. Physiol. 276:1999;E642-E649.
5. Bradford M.M. A rapid and sensitive method for the quantitaion of micrograms quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1976;248-254.
6. Cole N.B., Murphy D.D., Grider T., Rueter S., Brasaemle D., Nussbaum R.L. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem. 277:2002;6344-6352.
7. Crawford G.D.J., Le W.D., Smith R.G., Xie W.J., Stefani E., Appel S.H. A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12:1992;3382-3398.
8. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273:1998;9443-9449.
9. den Hartog Jager W.A. Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. Arch. Neurol. 21:1969;615-619.
10. Eylar E.H., Salk J., Beveridge G.C., Brown L.V. Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. Arch. Biochem. Biophys. 132:1969;34-48.
11. Feany M.B., Bender M.W. A drosophila model of Parkinson's disease. Nature. 404:2000;394-398.
12. Gai W.P., Yuan H.X., Li X.Q., Power J.T., Blumbergs P.C., Jensen P.H. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166:2000;324-333.
13. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 15:1995;361-372.
14. Giasson B.I., Duda J.E., Quinn S.M., Zhang B., Trojanowski J.Q., Lee V.M. Neuronal alpha-Synucleinopathy with severe movement disorder in mice expressing A53T human alpha-Synuclein. Neuron. 34:2002;521-533.
15. Hamilton J.A. Transport of fatty acids across membranes by the diffusion mechanism. Prostaglandins Leukot. Essent. Fatty Acids. 60:1999;291-297.
16. Hamilton J.A., Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes. 48:1999;2255-2269.
17. Hashimoto M., Rockenstein E., Mante M., Mallory M., Masliah E. beta-Synuclein inhibits alpha-synuclein aggregation. a possible role as an anti-parkinsonian factor Neuron. 32:2001;213-223.
18. Kahle P.J., Neumann M., Ozmen L., Muller V., Odoy S., Okamoto N., Jacobsen H., Iwatsubo T., Trojanowski J.Q., Takahashi H.et al. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am. J. Pathol. 159:2001;2215-2225.
19. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 2:1998;106-108.
20. Lee M.K., Stirling W., Xu Y., Xu X., Qui D., Mandir A.S., Dawson T.M., Copeland N.G., Jenkins N.A., Price D.L. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA. 99:2002;8968-8973.
21. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in a-Synuclein mice. implications for neurodegenerative disorders Science. 287:2000;1265-1269.
22. McLean P., Kawamata H., Ribich S., Hyman B.T. Membrane association and protein conformation of a-Synuclein in intact neurons. J. Biol. Chem. 275:2000;8812-8816.
23. Nelson, D.L., and Cox, M.M. (2000). Lehninger Principles of Biochemistry, 3rd Edition, chapter 17 (New York: Worth Publishers).
24. Oshiro Y., Eylar E.H. Allergic encephalomyelitis. preparation of the encephalitogenic basic protein from bovine brain Arch. Biochem. Biophys. 138:1970;392-396.
25. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Interaction of human a-Synuclein and Parkinson's disease variants with phospholipids. J. Biol. Chem. 275:2000;34393-34398.
26. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276:2001;41958-41962.
27. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R.et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
28. Richieri G.V., Ogata R.T., Kleinfeld A.M. A fluorescently labeled intestinal fatty acid binding protein. Interactions with fatty acids and its use in monitoring free fatty acids. J. Biol. Chem. 267:1992;23495-23501.
29. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
30. Sharon R., Goldberg M.S., Bar-Josef I., Betensky R.A., Shen J., Selkoe D.J. alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl. Acad. Sci. USA. 98:2001;9110-9115.
31. Souza J.M., Giasson B.I., Lee V.M., Ischiropoulos H. Chaperone-like activity of synucleins. FEBS Lett. 474:2000;116-119.
32. Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., Goedert M. aSynuclein in lewy bodies. Nature. 388:1997;389-390.
33. Spillantini M.G., Crowter R.A., Jakes R., Hasegawa M., Goedert M. a-Synuclein in filamentous inclusions of lewy bodies from parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA. 95:1998;6469-6473.
34. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
35. Xu J., Kao S.Y., Lee F.J., Song W., Jin L.W., Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein. a mechanism for selective neurodegeneration in Parkinson disease Nat. Med. 8:2002;600-606.
36. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., Chalon S. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex. a microdialysis study Neurosci. Lett. 240:1998;177-181.
37. Zimmer L., Delpal S., Guilloteau D., Aioun J., Durand G., Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci. Lett. 284:2000;25-28.